Goldman Sachs Future Heal... (GDOC)
AMEX: GDOC
· Real-Time Price · USD
32.96
0.26 (0.78%)
At close: Sep 05, 2025, 3:59 PM
32.96
-0.01%
After-hours: Sep 05, 2025, 04:04 PM EDT
0.78% (1D)
| Bid | 27.08 |
| Market Cap | 19.41M |
| AUM | 19.83M |
| NAV | 31.72 |
| EPS (ttm) | 0.99 |
| PE Ratio (ttm) | 33.24 |
| Shares Out | 589.02K |
| Inception Date | Nov 9, 2021 |
| Ask | 33.02 |
| Volume | 182 |
| Open | 32.96 |
| Previous Close | 32.70 |
| Day's Range | 32.96 - 33.00 |
| 52-Week Range | 28.34 - 36.78 |
| Holdings | 37 |
| Expense Ratio | 0.75% |
About GDOC
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.
Asset Class Equity
Ticker Symbol GDOC
Inception Date Nov 9, 2021
Provider Goldman Sachs
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 53.19% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 9.64% |
| Boston Scientific Co... | BSX | 8.39% |
| Abbott Laboratories | ABT | 5.39% |
| Intuitive Surgical, ... | ISRG | 5.27% |
| Abbvie Inc. | ABBV | 5.11% |
| Unitedhealth Group I... | UNH | 4.98% |
| Insulet Corporation | PODD | 4.30% |
| Astrazeneca PLC | AZN | 4.03% |
| Thermo Fisher Scient... | TMO | 3.17% |
| Biomarin Pharmaceuti... | BMRN | 2.91% |
Dividends Dividend Yield 0.02%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $0.0058 | Dec 30, 2024 |
| Dec 26, 2023 | $0.1789 | Jan 2, 2024 |
